Jean-Nicolas Soret
Partner
Practice areas
Career:
- Bar admission: 2000
- Graduated from ESCP Europe Business School and holds a Masters in Business Law and Taxation from the University of Paris II Panthéon-Assas
- Partner at Reed Smith LLP
- Partner at ADVANT Altana since 2010 and member of ADVANT steering committee with Advant Nctm and Advant Beiten’s representatives.
Areas of expertise:
- Mergers & Acquisitions, Joint Venture, Company Law, Stock Exchange Law
- Particular focus on cross-border transactions
Practice Areas:
- specialize in public and private mergers and acquisitions and joint ventures, with a particular focus on private cross-border M&A transactions.
- his expertise includes acquisitions and sales of companies and groups, strategic partnerships and joint venture agreements, takeover bids, disposals of non-core assets, reorganizations of groups and shareholding structures, and corporate governance.
- he has a particular interest in the life sciences, high-tech innovation and renewable energy sectors.
Languages:
- French
- English
- Spanish
Distinctions:
- Best Lawyers – recognized since 2020 (Biotechnology and Life Sciences Practice | Mergers and Acquisitions Law)
- Chambers Global 2023 – Corporate/M&A : High-end Capability – Tier 6
- Chambers Europe 2023 – Corporate/M&A : High-end Capability – Tier 6
- Legal 500 EMEA 2023 – Industry Focus : Healthcare & Life Sciences – Tier 1
- Legal 500 EMEA 2023 – Mergers & Acquisitions – Tier 4
- Option Droit & Affaires 2022 – M&A : Top Law Firms in France M&A deals up to €200 M – 4 stars
- Le Point/Statista 2023 – Palmarès des Meilleurs cabinets d’avocats – Fusions & Acquisitions – 5 stars
- Décideurs (Leaders League) 2022 – Mergers & Acquisitions : Operations worth between 75 M€ et 500 M€ – Excellent
- Décideurs (Leaders League) 2022 – Santé, Pharma & Biotechnologies : Opérations de Capital Risque – Forte notoriété
- Décideurs (Leaders League) 2022 – Santé, Pharma & Biotechnologies : Opérations de Capital, Joint-Ventures et Corporate – Forte notoriété
Publications :
- “Fusions-Acquisitions : Les Impacts D’Une Crise Inédite” – Forbes France – April 2020
- “Foreign Direct Investment under Greater European and French Scrutiny” – The American Lawyer – May 2018
- “Shareholder activism in France : a growing threat” [L’activisme actionnarial en France : Une menace grandissante] – The American Lawyer (Focus International, Winter 2017) – Janvier 2017
- “Acquiring a carved out business in France, the usual suspects and the French touch” – The American Lawyer Magazine – Mai 2016
- “FDI: France’s attractiveness is growing again” [Investissements directs étrangers : la France redevient plus attractive] – The American Lawyer Magazine – Octobre 2014
- “BioAlliance Pharma and Topotarget enter into a Cross-Border Merger Agreement” [BioAlliance Pharma et Topotarget réalisent une Fusion Transfrontalière] – Lawyer Monthly – Septembre 2014
- “Fusions transfrontalières de sociétés cotées : quand l’Europe des entreprises devient une réalité” – Option Finance – Septembre 2014
- “The Initial Bond Offering, The future of SMEs financing” – Financier Worldwide – Avril 2013
- “L’IBO, un excellent outil de financement alternatif pour les ETI” – Décideurs – Mars 2013
- “Global M&A / France” – American Lawyer – Janvier 2013
- “Key concepts involved in acquisitions of ailing manufacturing companies in France” – Doing business in France – Edition 2012
- “Réussir ses carve out et transferts d’activités” – CF News – Février 2012
- “Alternext, un marché redynamisé” – Décideurs – Novembre 2010
- “Communiquer sur ses difficultés, un exercice toujours délicat pour les sociétés cotées” – Option Finance – Septembre 2009
- “Advantages Of A Dual Listing On NYSE-Euronext” – Law 360° – Août 2008
Interviews :
- « Les acteurs du M&A doivent préparer l’avenir », L’Agefi, April 2020
- « La gouvernance reste un enjeu central pour les entreprises familiales », l’Agefi, October 2019
- « Au secourts, mon fournisseur veut entret au capital », Les Echos, January 2018
- The American Lawyer, « Keeping M&A afloat in France », janvier 2016
- Option Finance, « Fusion transfrontalière entre Bioalliance Pharma et Topotarget», September 2014
- The American Lawyer, « The French Paradox », February 2014
- The American Lawyer, « France, critical measures », May 2013
- Capital Finance, « Alternext a gagné en intérêt », July 2011
International Conferences:
- February 2017, International Bar Association, Paris: speaker on a panel presentation on “European Share for Share Deals”
- February 2014, International Bar Association, Paris: speaker on a panel presentation on “The colour of money: anti-bribery and M&A”
- October 2013, International Bar Association, Boston: speaker on a panel presentation on “Letters of intent, confidentiality agreements and other pre-contractual agreements”
Associations:
- ESCP Europe Alumni
- International Bar Association
- Institut Français des Administrateurs (French Directors’ Association)
Linked news
ADVANT Altana has advised LEXISNEXIS on its acquisition of CASE LAW ANALYTICS
28/08/2023
- Articles and publications
LexisNexis, a global provider of information-based analytics and decision tools, part of the… Read more
ADVANT Altana a conseillé le groupe agroalimentaire coopératif breton Eureden dans le cadre de la cession de Sicarbu Ouest à Bolloré Energy
21/07/2023
- Articles and publications
Sorry, this entry is only available in… Read more
ADVANT Altana conseille Docaposte dans le cadre de l’acquisition d’une participation majoritaire au capital de Weliom
17/07/2023
- Articles and publications
Sorry, this entry is only available in… Read more
View all news
ADVANT Altana has advised LEXISNEXIS on its acquisition of CASE LAW ANALYTICS
28/08/2023 - Articles and publications
LexisNexis, a global provider of information-based analytics and decision tools, part of the… Read more
ADVANT Altana a conseillé le groupe agroalimentaire coopératif breton Eureden dans le cadre de la cession de Sicarbu Ouest à Bolloré Energy
21/07/2023 - Articles and publications
Sorry, this entry is only available in… Read more
ADVANT Altana conseille Docaposte dans le cadre de l’acquisition d’une participation majoritaire au capital de Weliom
17/07/2023 - Articles and publications
Sorry, this entry is only available in… Read more